KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $30.9 million.

  • Chemed's Change in Receivables rose 15966.93% to $30.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.4 million, marking a year-over-year decrease of 3070.66%. This contributed to the annual value of -$10.7 million for FY2024, which is 12573.76% down from last year.
  • Per Chemed's latest filing, its Change in Receivables stood at $30.9 million for Q3 2025, which was up 15966.93% from -$54.0 million recorded in Q2 2025.
  • In the past 5 years, Chemed's Change in Receivables ranged from a high of $67.4 million in Q1 2025 and a low of -$54.0 million during Q2 2025
  • Its 5-year average for Change in Receivables is $4.5 million, with a median of $11.9 million in 2024.
  • In the last 5 years, Chemed's Change in Receivables skyrocketed by 432740.05% in 2021 and then crashed by 79470.84% in 2025.
  • Quarter analysis of 5 years shows Chemed's Change in Receivables stood at $17.7 million in 2021, then grew by 5.1% to $18.6 million in 2022, then fell by 26.56% to $13.6 million in 2023, then plummeted by 283.32% to -$25.0 million in 2024, then surged by 223.68% to $30.9 million in 2025.
  • Its Change in Receivables was $30.9 million in Q3 2025, compared to -$54.0 million in Q2 2025 and $67.4 million in Q1 2025.